Bio X Cell Announces CEO Appointment
News provided by Bio X Cell 12 Aug, 2024, 06:00 GMT A Leading Producer of Monoclonal Antibodies LEBANON, N.H., Aug. 12, 2024 /PRNewswire/ — Bio X Cell, LLC (“BXC” or the “Company”), a leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointment of Christopher Conway as Chief Executive Officer. Mr. Conway has extensive experience in both small molecule and Biologics drug discovery, most … Continue reading Bio X Cell Announces CEO Appointment